Nucleic Acids Research, 1991, Vol. 19, No. 4 751-757
© 1991
MOLECULAR BIOLOGY |
Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNALys,3
CRBGC du CNRS, 118 Route de Narbonne, 31 062 Toulouse 1 LaboRetro, Ecole Normale Superieure de Lyon, 46 allée d'ltalie, 69364 Lyon, France 2Central Research Units F.Hoffmann-La Roche Ltd, Basel, Switzerland
* To whom correspondence should be addressed
Received November 30, 1990. Revised January 21, 1991. Accepted January 21, 1991.
Using synthetic oligonucleotides, a gene encoding the HIV-1 replication primer, tRNALys,3, was constructed and placed downstream from a bacteriophage T7 promoter. In vitro transcription of this gene yielded a form of tRNALys,3 which lacks the modified bases characteristic of the natural species and the 3'-G-A-dinucieotide. Synthetic tRNALys,3 annealed to a pbs- HIV1 RNA template can prime cDNA synthesis catalysed by recombinant HIV-1 reverse transcriptase. Trans-DDP crosslinking indicates that this synthetic tRNA is still capable of interacting with HIV-1 RT via a 12-nucleotide portion encompassing the anticodon domain. Gel-mobility shift and competition analyses imply that the affinity of synthetic tRNA for RT is reduced. In contrast to earlier observations, synthetic tRNA is readily competed from RT by natural tRNAPro. The reduced affinity of synthetic tRNALys,3 for RT is not appreciably affected by mutations in positions within the loop of the anticodon domain. These results would imply that the overall structure of the anticodon domain of tRNALys,3 is an important factor in its recognition by HIV-1 RT. In addition, modified bases within this, although not absolutely required, would appear to make a significant contribution to the enhanced stability of the ribonucleoprotein complex.
+ Present address: Division of Infectious Diseases. Case Western Reserve University School of Medicine. 2109 Adelbert Road, Cleveland. Ohio 44105, USA
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Gabus, R. Ivanyi-Nagy, J. Depollier, A. Bucheton, A. Pelisson, and J.-L. Darlix Characterization of a nucleocapsid-like region and of two distinct primer tRNALys,2 binding sites in the endogenous retrovirus Gypsy Nucleic Acids Res., November 6, 2006; 34(20): 5764 - 5777. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Roldan, O. U. Warren, R. S. Russell, C. Liang, and M. A. Wainberg A HIV-1 Minimal Gag Protein Is Superior to Nucleocapsid at in Vitro Annealing and Exhibits Multimerization-induced Inhibition of Reverse Transcription J. Biol. Chem., April 29, 2005; 280(17): 17488 - 17496. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cristofari, R. Ivanyi-Nagy, C. Gabus, S. Boulant, J.-P. Lavergne, F. Penin, and J.-L. Darlix The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro Nucleic Acids Res., May 11, 2004; 32(8): 2623 - 2631. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Pata, B. R. King, and T. A. Steitz Assembly, purification and crystallization of an active HIV-1 reverse transcriptase initiation complex Nucleic Acids Res., November 15, 2002; 30(22): 4855 - 4863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Lund, M. Duch, and F. S. Pedersen Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication Nucleic Acids Res., February 1, 2000; 28(3): 791 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Lund, J. Schmidt, A. Luz, A. B. Sørensen, M. Duch, and F. S. Pedersen Replication and Pathogenicity of Primer Binding Site Mutants of SL3-3 Murine Leukemia Viruses J. Virol., July 1, 1999; 73(7): 6117 - 6122. [Abstract] [Full Text] |
||||
![]() |
C. Ulich, A. Dunne, E. Parry, C. W. Hooker, R. B. Gaynor, and D. Harrich Functional Domains of Tat Required for Efficient Human Immunodeficiency Virus Type 1 Reverse Transcription J. Virol., March 1, 1999; 73(3): 2499 - 2508. [Abstract] [Full Text] |
||||
![]() |
S. Auxilien, G. Keith, S. F. J. Le Grice, and J.-L. Darlix Role of Post-transcriptional Modifications of Primer tRNALys,3 in the Fidelity and Efficacy of Plus Strand DNA Transfer during HIV-1 Reverse Transcription J. Biol. Chem., February 12, 1999; 274(7): 4412 - 4420. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Gregoire, D. Gautheret, and E. P. Loret No tRNA3Lys Unwinding in a Complex with HIV NCp7 J. Biol. Chem., October 3, 1997; 272(40): 25143 - 25148. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lu, V. Planelles, X. Li, C. Palaniappan, B. Day, P. Challita-Eid, R. Amado, D. Stephens, D. B. Kohn, A. Bakker, et al. Inhibition of HIV-1 Replication Using a Mutated tRNALys-3 Primer J. Biol. Chem., June 6, 1997; 272(23): 14523 - 14531. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. O. Essink, A. T. Das, and B. Berkhout Structural Requirements for the Binding of tRNA(3)[IMAGE] to Reverse Transcriptase of the Human Immunodeficiency Virus Type 1 J. Biol. Chem., October 6, 1995; 270(40): 23867 - 23874. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mély, H. de Rocquigny, M. Sorinas-Jimeno, Gér. Keith, B. P. Roques, R. Marquet, and D. Gérard Binding of the HIV-1 Nucleocapsid Protein to the Primer tRNA(3)[IMAGE], inVitro, Is Essentially Not Specific J. Biol. Chem., January 27, 1995; 270(4): 1650 - 1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Francin, M. Kaminska, P. Kerjan, and M. Mirande The N-terminal Domain of Mammalian Lysyl-tRNA Synthetase Is a Functional tRNA-binding Domain J. Biol. Chem., January 11, 2002; 277(3): 1762 - 1769. [Abstract] [Full Text] [PDF] |
||||


